A Novel 99mTc-Labeled Molecular Probe for Tumor Angiogenesis Imaging in Hepatoma Xenografts Model: A Pilot Study

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhao, Qian ^a   Yan, Ping ^a   Wang, Rong Fu ^a   Zhang, Chun Li ^a   Li, Ling ^a   Yin, Lei ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININYLARGININYLLEUCINE; ARGININYLARGININYLLEUCINE TC 99M; FLUORODEOXYGLUCOSE F 18; PERTECHNETIC ACID; TRACER; TRIPEPTIDE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; OLIGOPEPTIDE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M ARGINYL ARGINYL LEUCINE; TECHNETIUM 99M ARGINYL-ARGINYL-LEUCINE; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SIZE; CELL STRAIN HEPG2; DIAGNOSTIC IMAGING; DIAGNOSTIC IMAGING EQUIPMENT; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG PURITY; DRUG STABILITY; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; ISOTOPE LABELING; KIDNEY; LIVER CELL CARCINOMA; MOLECULAR PROBE; MOUSE; MUSCLE; NON INVASIVE PROCEDURE; NONHUMAN; PEPTIDE SYNTHESIS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; ROOM TEMPERATURE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR ANGIOGENESIS IMAGING; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; LIVER TUMOR; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PATHOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION; TUMOR VOLUME; VASCULARIZATION;

MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; ORGANOTECHNETIUM COMPOUNDS; PILOT PROJECTS; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TUMOR BURDEN;

EID: 84875695779     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061043     Document Type: Article

References (30)

1. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML, (2011) Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 103: 117-128.
2. Glunde K, Pathak AP, Bhujwalla ZM, (2007) Molecular-functional imaging of cancer: to image and imagine. Trends Mol Med 13: 287-297.
3. Fan F, Schimming A, Jaeger D, Podar K, (2012) Targeting the tumor microenvironment: focus on angiogenesis. J Oncol 2012: 281261.
4. Li WW, Li VW, Hutnik M, Chiou AS, (2012) Tumor angiogenesis as a target for dietary cancer prevention. J Oncol 2012: 879623.
5. Weis SM, Cheresh DA, (2011) Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med 17: 1359-1370.
6. Kume T, (2012) The Role of FoxC2 Transcription Factor in Tumor Angiogenesis. J Oncol 2012: 204593.
7. Larsen AK, Ouaret D, El Ouadrani K, Petitprez A, (2011) Targeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis. Pharmacol Ther 131: 80-90.
8. Liu M, Wang RF, Zhang CL, Yan P, Yu MM, et al. (2007) Noninvasive Imaging of Human Tolemerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTc-Radiolabeled Antisense Probes in Malignant Tumors. J Nucl Med 48: 2028-2036.
9. Nannuru KC, Sharma B, Varney ML, Singh RK, (2011) Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. J Carcinog 10: 40.
10. Rodriguez S, Huynh-Do U, (2012) The Role of PTEN in Tumor Angiogenesis. J Oncol 2012: 141236.
11. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K, (2011) VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 17: 347-362.
12. Edwards WB, Akers WJ, Ye Y, Cheney PP, Bloch S, et al. (2009) Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide. Mol Imaging 8: 101-110.
13. Engle JW, Hong H, Zhang Y, Valdovinos HF, Myklejord DV, et al. (2012) Positron emission tomography imaging of tumor angiogenesis with a (66)ga-labeled monoclonal antibody. Mol Pharm 9: 1441-1448.
14. Kim YH, Jeon J, Hong SH, Rhim WK, Lee YS, et al. (2011) Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small 7: 2052-2060.
15. Liu S, Liu H, Jiang H, Xu Y, Zhang H, et al. (2011) One-step radiosynthesis of (1)(8)F-AlF-NOTA-RGD(2) for tumor angiogenesis PET imaging. Eur J Nucl Med Mol Imaging 38: 1732-1741.
16. Zhou Y, Chakraborty S, Liu S, (2011) Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT. Theranostics 1: 58-82.
17. Okarvi SM, (1999) Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview. Nucl Med Commun 20: 1093-1112.
18. Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, et al. (2005) Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 65: 533-539.
19. Yu M, Zhou H, Liu X, Huo Y, Zhu Y, et al. (2010) Study on biodistribution and imaging of radioiodinated arginine-arginine-leucine peptide in nude mice bearing human prostate carcinoma. Ann Nucl Med 24: 13-19.
20. Knowles BB, Howe CC, Aden DP, (1980) Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 209: 497-499.
21. Brown CK, Modzelewski RA, Johnson CS, Wong MK, (2000) A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library. Ann Surg Oncol 7: 743-749.
22. Lu X, Yan P, Wang R, Meng Liu MY, Zhang C, et al. (2011) The further study on radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging J Radioanal Nucl Ch. 290: 623-630.
23. Lu X, Yan P, Wang R-f, Liu M, Yu M-m, et al. (2012) Use of radioiodinated peptide Arg-Arg-Leu targeted to neovascularization as well as tumor cells in molecular tumor imaging. Chinese J Cancer Res 24: 52-59.
24. HP V, GM B, MK DR, AM V, (1995) Complexes of technetium-99 m with tetrapeptides, a new class of Tc-99 m labeled agents. Nucl Med Biol 33: 325-338.
25. Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, et al. (2007) Evaluation of a (99 m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer. Bioconjug Chem 18: 438-446.
26. Fani M, Psimadas D, Zikos C, Xanthopoulos S, Loudos GK, et al. (2006) Comparative evaluation of linear and cyclic 99mTc-RGD peptides for targeting of integrins in tumor angiogenesis. Anticancer Res 26: 431-434.
27. Pathuri G, Hedrick AF, Disch BC, Doan JT, Ihnat MA, et al. (2012) Synthesis and evaluation of novel Tc-99 m labeled probestin conjugates for imaging APN/CD13 expression in vivo. Bioconjug Chem 23: 115-124.
28. Priyadarshani A, Chuttani K, Mittal G, Bhatnagar A (2010) Radiolabeling, biodistribution and gamma scintigraphy of noscapine hydrochloride in normal and polycystic ovary induced rats. J Ovarian Res 3.
29. Knight LC, Romano JE, Bright LT, Agelan A, Kantor S, et al. (2007) Platelet binding and biodistribution of [99mTc]rBitistatin in animal species and humans. Nucl Med Biol 34: 855-863.
30. Behr TM, Goldenberg DM, Becker W, (1998) Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations. Eur J Nucl Med 25: 201-212.